Physician

Richard A. Sater, MD, PHD

According to 2025 Medicare claims, Richard Sater, MD, PHD (NPI: 1174543805) practices neurology in the Greensboro-High Point, NC market, with the plurality of this provider's patient population coming from Guilford, NC. This provider's primary affiliated billing organization is MOSES CONE AFFILIATED PHYSICIANS, INC. (NPI: 1770821233; TIN: 300554775) and primary practice location at 27405-6967. Sater is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Triad HealthCare Network, LLC. (ACO ID: D0209), participating under both the MSSP and REACH models.

Sater's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 242 traditional Medicare patients, billed 20,303 HCPCS/CPT codes, and received $636,365 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 5,911 prescription claims across 564 beneficiaries totaling $4,475,011 in drug costs, led by Soliris (Eculizumab). DME data shows 61 claims. Open Payments data shows 274 records totaling $214,898. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $70,825 to $28,073.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	566	37,053	$599,107
2016	409	26,999	$495,696
2017	492	26,665	$715,862
2018	434	32,372	$803,321
2019	399	34,760	$829,220
2020	309	32,615	$714,942
2021	343	24,821	$670,649
2022	308	16,393	$582,612
2023	292	21,377	$589,065
2024	242	20,303	$636,365

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	585	7,391	$5,214,919
2016	380	5,141	$4,317,576
2017	354	6,042	$5,124,503
2018	410	6,106	$6,037,274
2019	437	5,852	$6,253,193
2020	446	5,917	$6,100,987
2021	471	5,337	$5,287,870
2022	462	4,889	$4,395,962
2023	522	5,481	$4,589,972
2024	564	5,911	$4,475,011

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	317	656	$30,979
2016	183	385	$13,971
2017	52	156	$3,330
2018	60	161	$4,445
2019	26	124	$3,473
2020	43	194	$6,832
2021	24	163	$6,078
2022	N/R	110	$4,250
2023	49	148	$6,804
2024	N/R	61	$1,615

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	32	32	$150
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	39	47	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	95	121	$81
70553	Mri scan of brain before and after contrast	41	42	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	62	73	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Soliris	Eculizumab	11	308	$600,809
Ocrevus	Ocrelizumab	16	2,508	$587,007
Kesimpta Pen	Ofatumumab	44	1,292	$399,644
Aubagio	Teriflunomide	30	900	$277,896
Mayzent	Siponimod	26	780	$266,302

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	31	$897
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	N/R	17	$576
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	13	$142

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	268	$123,604	EMD Serono, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$91,294	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard A. Sater, MD, PHD?

Tedicare shows public-source Medicare data for Richard A. Sater, MD, PHD (NPI 1174543805), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard A. Sater, MD, PHD have ACO affiliation data?

Richard A. Sater, MD, PHD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Richard A. Sater, MD, PHD?

Richard A. Sater, MD, PHD is linked to MOSES CONE AFFILIATED PHYSICIANS, INC. (billing NPI 1770821233) in the available physician profile data.

Does Richard A. Sater, MD, PHD have Open Payments data?

Richard A. Sater, MD, PHD has 274 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.